Citation: Mc. Chamberlain et Pa. Kormanik, PRACTICAL GUIDELINES FOR THE TREATMENT OF MALIGNANT GLIOMAS, Western journal of medicine, 168(2), 1998, pp. 114-120
Citation: Mc. Chamberlain et P. Kormanik, SALVAGE CHEMOTHERAPY WITH TAMOXIFEN FOR RECURRENT ANAPLASTIC ASTROCYTOMAS (AA), Neurology, 50(4), 1998, pp. 6021-6021
Citation: Mc. Chamberlain et P. Kormanik, CARCINOMA MENINGITIS SECONDARY TO NONSMALL CELL LUNG-CANCER - COMBINED-MODALITY THERAPY, Archives of neurology, 55(4), 1998, pp. 506-512
Citation: Mc. Chamberlain et P. Kormanik, LYMPHOMATOUS MENINGITIS IN IMMUNOCOMPETENT PATIENTS - COMBINED-MODALITY THERAPY, Oncology Reports, 4(6), 1997, pp. 1311-1318
Authors:
CHAMBERLAIN MC
KORMANIK P
BARBA D
SAUNDERS W
FULLER B
SHEA WM
SMITH D
Citation: Mc. Chamberlain et al., CONCURRENT CARBOPLATIN AND I-125 BRACHYTHERAPY FOR RECURRENT GLIOBLASTOMA-MULTIFORME, International journal of oncology, 11(1), 1997, pp. 199-205
Citation: Mc. Chamberlain et Pa. Kormanik, SALVAGE CHEMOTHERAPY WITH PACLITAXEL FOR RECURRENT OLIGODENDROGLIOMAS, Journal of clinical oncology, 15(12), 1997, pp. 3427-3432
Citation: Mc. Chamberlain et P. Kormanik, CONCURRENT CARBOPLATIN AND I-125 BRACHYTHERAPY FOR RECURRENT GLIOBLASTOMA-MULTIFORME, Annals of neurology, 42(3), 1997, pp. 152-152
Citation: Mc. Chamberlain et P. Kormanik, NON-AIDS-RELATED LYMPHOMATOUS MENINGITIS - COMBINED-MODALITY THERAPY, Annals of neurology, 42(3), 1997, pp. 276-276
Citation: Mc. Chamberlain et P. Kormanik, CARCINOMATOUS MENINGITIS SECONDARY TO NONSMALL CELL LUNG-CANCER - COMBINED-MODALITY THERAPY, Annals of neurology, 42(3), 1997, pp. 280-280
Citation: Mc. Chamberlain et Prn. Kormanik, CARCINOMATOUS MENINGITIS SECONDARY TO BREAST-CANCER - PREDICTORS OF RESPONSE TO COMBINED-MODALITY THERAPY, Journal of neuro-oncology, 35(1), 1997, pp. 55-64
Citation: Pa. Kormanik et Mc. Chamberlain, COMPLICATIONS ASSOCIATED WITH INTRAVENTRICULAR CHEMOTHERAPY IN PATIENTS WITH LEPTOMENINGEAL METASTASES, Neurology, 48(3), 1997, pp. 1013-1013
Citation: Mc. Chamberlain et al., COMPLICATIONS ASSOCIATED WITH INTRAVENTRICULAR CHEMOTHERAPY IN PATIENTS WITH LEPTOMENINGEAL METASTASES, Journal of neurosurgery, 87(5), 1997, pp. 694-699